title: ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
abstract: Heterozygous carriers of ATM (ataxia telangiectasia mutated gene) mutations have increased risk of breast cancer (BC). We have estimated the prevalence of mutations in the ATM gene among Spanish patients with early-onset BC. Forty-three patients diagnosed with BC before the age of 46 years, and negative for BRCA1 and BRCA2 mutations, were analysed for the presence of ATM mutations. A total of 34 ATM sequence variants were detected: 1 deleterious mutation, 10 unclassified variants and 23 polymorphisms. One patient (2.3%) carried the ATM deleterious mutation (3802delG that causes ataxia telangiectasia in the homozygous state) and 13 patients carried the 10 ATM unclassified variants. The truncating mutation 3802delG and eight of the rare variants were not detected in a control group of 150 individuals. Different bioinformatic sequence analysis tools were used to evaluate the effects of the unclassified ATM changes on RNA splicing and function protein. This in silico analysis predicted that the missense variants 7653 T>C and 8156 G>A could alter the splicing by disrupting an exonic splicing enhancer motif and the 3763 T>G, 6314 G>C, and 8156 G>A variants would affect the ATM protein function. These are the initial results concerning the prevalence of germline mutations in the ATM gene among BC cases in a Spanish population, and they suggest that ATM mutations can confer increased susceptibility to early-onset BC.
authors.affiliation: Institut d'Investigació Biomèdica de Girona, Institut Català d'Oncologia, Hospital Josep Trueta, Girona, Catalonia, Spain. jbrunet@ico.scs.es
authors.forename: J
authors.initials: J
authors.lastname: Brunet
authors.forename: S
authors.initials: S
authors.lastname: Gutiérrez-Enríquez
authors.forename: A
authors.initials: A
authors.lastname: Torres
authors.forename: V
authors.initials: V
authors.lastname: Bérez
authors.forename: S
authors.initials: S
authors.lastname: Sanjosé
authors.forename: J
authors.initials: J
authors.lastname: Galceran
authors.forename: A
authors.initials: A
authors.lastname: Izquierdo
authors.forename: J A
authors.initials: JA
authors.lastname: Menéndez
authors.forename: J
authors.initials: J
authors.lastname: Gumà
authors.forename: J
authors.initials: J
authors.lastname: Borràs
mesh_terms: D000328:Adult; D064007:Ataxia Telangiectasia Mutated Proteins; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics*; D018797:Cell Cycle Proteins / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease; D018095:Germ-Line Mutation; D006801:Humans; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D025521:Tumor Suppressor Proteins; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases